Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hilgeroth

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitorsMartin Krug, German Erlenkamp, Wolfgang Sippl, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenesBurkhardt Voigt, Laurent Meijer, Olivier Lozach, et al.
Molecules (Basel, Switzerland)|December 14, 2017
Novel Effective Small-Molecule Antibacterials against Enterococcus StrainsKerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Novel Small-Molecule Hybrid-Antibacterial Agents against <i>S. aureus</i> and MRSA StrainsRobin Gehrmann, Tobias Hertlein, Elisa Hopke, et al.
Molecules (Basel, Switzerland)|August 11, 2019
Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of ClofazimineFabian Lentz, Norbert Reiling, Gabriella Spengler, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1RCornelius Hempel, Frank Totzke, Christoph Schächtele, et al.
Antibiotics (Basel, Switzerland)|November 6, 2019
Novel Small-molecule Antibacterials against Gram-positive Pathogens of <i>Staphylococcus</i> and <i>Enterococcus</i> SpeciesMarius Seethaler, Tobias Hertlein, Björn Wecklein, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 24, 2015
Novel 4-anilino-α-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activityMarkus Oelze, Kazem Ahmed Mahmoud, Wolfgang Sippl, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 4, 2017
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistanceTim Fischer, Abdulkarim Najjar, Frank Totzke, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Novel Effective Fluorinated Benzothiophene-Indole Hybrid Antibacterials against <i>S. aureus</i> and MRSA StrainsMarius Seethaler, Tobias Hertlein, Elisa Hopke, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitorsMartin Krug, German Erlenkamp, Wolfgang Sippl, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenesBurkhardt Voigt, Laurent Meijer, Olivier Lozach, et al.
Molecules (Basel, Switzerland)|December 14, 2017
Novel Effective Small-Molecule Antibacterials against Enterococcus StrainsKerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Novel Small-Molecule Hybrid-Antibacterial Agents against <i>S. aureus</i> and MRSA StrainsRobin Gehrmann, Tobias Hertlein, Elisa Hopke, et al.
Molecules (Basel, Switzerland)|August 11, 2019
Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of ClofazimineFabian Lentz, Norbert Reiling, Gabriella Spengler, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1RCornelius Hempel, Frank Totzke, Christoph Schächtele, et al.
Antibiotics (Basel, Switzerland)|November 6, 2019
Novel Small-molecule Antibacterials against Gram-positive Pathogens of <i>Staphylococcus</i> and <i>Enterococcus</i> SpeciesMarius Seethaler, Tobias Hertlein, Björn Wecklein, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 24, 2015
Novel 4-anilino-α-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activityMarkus Oelze, Kazem Ahmed Mahmoud, Wolfgang Sippl, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 4, 2017
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistanceTim Fischer, Abdulkarim Najjar, Frank Totzke, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Novel Effective Fluorinated Benzothiophene-Indole Hybrid Antibacterials against <i>S. aureus</i> and MRSA StrainsMarius Seethaler, Tobias Hertlein, Elisa Hopke, et al.
Pageof 7